Hennion & Walsh Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.23M | Sell |
51,079
-38,543
| -43% | -$2.44M | 0.13% | 199 |
|
|
2025
Q1 | $4.75M | Sell |
89,622
-9,825
| -10% | -$520K | 0.21% | 106 |
|
|
2024
Q4 | $5.57M | Sell |
99,447
-1,514
| -1% | -$84.8K | 0.25% | 84 |
|
|
2024
Q3 | $5.29M | Buy |
100,961
+4,583
| +5% | +$240K | 0.25% | 90 |
|
|
2024
Q2 | $3.96M | Buy |
96,378
+9,411
| +11% | +$386K | 0.2% | 119 |
|
|
2024
Q1 | $3.77M | Buy |
86,967
+20,259
| +30% | +$878K | 0.2% | 126 |
|
|
2023
Q4 | $3.07M | Buy |
66,708
+26,562
| +66% | +$1.22M | 0.18% | 160 |
|
|
2023
Q3 | $920K | Buy |
40,146
+18,963
| +90% | +$435K | 0.06% | 376 |
|
|
2023
Q2 | $349K | Sell |
21,183
-36,152
| -63% | -$596K | 0.02% | 610 |
|
|
2023
Q1 | $1.02M | Sell |
57,335
-1,963
| -3% | -$35K | 0.06% | 352 |
|
|
2022
Q4 | $1.73M | Buy |
59,298
+7,496
| +14% | +$218K | 0.11% | 227 |
|
|
2022
Q3 | $1.27M | Sell |
51,802
-717
| -1% | -$17.6K | 0.08% | 275 |
|
|
2022
Q2 | $218K | Sell |
52,519
-781
| -1% | -$3.24K | 0.01% | 709 |
|
|
2022
Q1 | $614K | Buy |
53,300
+1,088
| +2% | +$12.5K | 0.03% | 470 |
|
|
2021
Q4 | $521K | Buy |
52,212
+3,262
| +7% | +$32.6K | 0.03% | 532 |
|
|
2021
Q3 | $639K | Buy |
48,950
+16,757
| +52% | +$219K | 0.03% | 455 |
|
|
2021
Q2 | $630K | Buy |
32,193
+505
| +2% | +$9.88K | 0.03% | 473 |
|
|
2021
Q1 | $674K | Buy |
+31,688
| New | +$674K | 0.04% | 444 |
|